Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Cancer Research UK
Arcus Biosciences, Inc.
Cedars-Sinai Medical Center
University of Pennsylvania
Scripps Health
Celgene
Memorial Sloan Kettering Cancer Center
Shenzhen BinDeBio Ltd.
Celgene
Novartis
Mirna Therapeutics, Inc.
Shenzhen Second People's Hospital
Celldex Therapeutics
M.D. Anderson Cancer Center
Bayer
Rutgers, The State University of New Jersey
The Cleveland Clinic
INSYS Therapeutics Inc
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center